Health Canada drug identification number

DIN 02563533 — ZURZUVAE 25 MG

ZURZUVAE is a capsule of Zuranolone marketed by BIOGEN CANADA INC. The full Zuranolone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02563533
Brand name
ZURZUVAE
Active ingredient
Zuranolone
Strength
25 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
BIOGEN CANADA INC
Health Canada status
MARKETED
Drug class
Neuroactive steroid GABA-A receptor modulator (antidepressant)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Zuranolone products

DINBrandStrengthFormManufacturerStatus
02563525 ZURZUVAE 20 MG CAPSULE BIOGEN CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.